{
    "2021-11-12": [
        [
            {
                "time": "",
                "original_text": "智飞生物：目前公司管线内有26个在研项目，主要涉及预防肺结核、肺炎、流脑、流感、狂犬病等人用疫苗项目",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "在研项目",
                        "疫苗",
                        "肺结核",
                        "肺炎",
                        "流脑",
                        "流感",
                        "狂犬病"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药板块2021Q3分析暨11月月报：高基数下增速放缓 板块基本面依旧强劲 把握配置窗口期",
                "features": {
                    "keywords": [
                        "医药板块",
                        "2021Q3",
                        "高基数",
                        "增速放缓",
                        "基本面强劲",
                        "配置窗口期"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}